Picture of Nyxoah SA logo

NYXH — Nyxoah SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Nyxoah 'Better Sleep' Trial Reaches Its Primary Endpoints

June 7 (Reuters) - Nyxoah SA  NYXH.BR :
    * NYXOAH BETTER SLEEP TRIAL REACHES ITS PRIMARY ENDPOINTS
    * EXPECTS TO ANNOUNCE ADDITIONAL DATA WITH RESPECT TO STUDY AS FURTHER
ANALYSES
ARE CONDUCTED
    * TOP-LINE RESULTS FROM BETTER SLEEP STUDY SHOWED:
    * A STATISTICALLY SIGNIFICANT MEAN REDUCTION IN APNEA HYPOPNEA INDEX (AHI)
FROM
BASELINE TO SIX MONTHS POST IMPLANTATION IN WHOLE COHORT (CCC AND NON-CCC
PATIENTS)
    * A STATISTICALLY SIGNIFICANT MEAN REDUCTION IN AHI FROM BASELINE TO SIX
MONTHS
POST IMPLANTATION IN CCC PATIENT SUBGROUP
    * 42.9% OF STUDY POPULATION HAD CCC

Source text for Eikon:  ID:nGNE6qQNbF 
Further company coverage:  NYXH.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Nyxoah SA

See all news